FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W475345> ?p ?o ?g. }

• W475345 endingPage "81" @default.
• W475345 startingPage "S75" @default.
• W475345 abstract "Whether and when is it possible to completely stop immunosuppression in patients with lupus nephritis is still poorly defined.An attempt to slowly and progressively eliminate steroids and immunosuppressive drugs was tried in 73 of 161 (45.3%) patients with lupus nephritis who achieved a stable clinical remission defined as normal serum creatinine, proteinuria <0.5g/24h, inactive urine sediment, and no clinical signs of extra-renal activity of SLE for at least 12 months.Twenty-one out of the 73 patients (28.7%) who met the criteria for withdrawal of treatment developed flares during the phase of progressive reduction of therapy and their treatment was reinforced. Twenty patients entered remission again; the last patient was lost to follow-up at achievement of partial remission. In the other 52 of the 73 patients (71.2%), it was possible to completely withdraw treatment. Of these, 32 patients (group A) did not resume therapy for the subsequent follow-up (median 101.8 months); the other 20 patients (group B) had at least one flare, in median 37 months after withdrawing therapy, and had to be retreated. At the last observation, after a median follow-up of 286 months, 10 of these 20 patients were off therapy. At the last observation, two patients in group A and two in group B had died, no patient of group A and two of group B had developed renal insufficiency (serum creatinine 2.5 and 3 mg/dl, respectively). Compared to patients in group B, group A patients received longer treatment (98.1 vs. 31.0 months; p=0.01), had longer remission (52.8 vs. 12.0 months; p=0.000) before withdrawal of therapy, and continued chloroquine after stopping therapy (52% vs. 10%; p=0.004). In comparison to patients who never stopped therapy, patients who were able to interrupt treatment had lower risk of chronic renal insufficiency (3.8% vs. 28.4%; p=0.000), end-stage renal disease (0 vs. 12.8%; p=0.01), arterial hypertension (32.7% vs. 66.9%; p=0.000) and cardiovascular events (11.5% vs. 27.5%; p=0.04).Complete withdrawal of therapy is feasible in selected patients who achieved stable remission after long-term treatment. The reduction of treatment must be done in a very gradual manner, progressively and under strict medical surveillance. The withdrawal of therapy allows the patients to reduce renal and extra-renal damage accrual. Treatment with chloroquine may help to maintain remission in patients who discontinue steroids and immunosuppressive drugs." @default.
• W475345 created "2016-06-24" @default.
• W475345 creator A5016156476 @default.
• W475345 creator A5045284474 @default.
• W475345 creator A5064594935 @default.
• W475345 creator A5073365136 @default.
• W475345 creator A5075216140 @default.
• W475345 date "2013-11-06" @default.
• W475345 modified "2023-10-16" @default.
• W475345 title "What happens after complete withdrawal of therapy in patients with lupus nephritis." @default.
• W475345 cites W1984266821 @default.
• W475345 cites W1984472505 @default.
• W475345 cites W1998405029 @default.
• W475345 cites W2000054950 @default.
• W475345 cites W2036892337 @default.
• W475345 cites W2071299644 @default.
• W475345 cites W2075452125 @default.
• W475345 cites W2092159811 @default.
• W475345 cites W2102134607 @default.
• W475345 cites W2103360186 @default.
• W475345 cites W2112719802 @default.
• W475345 cites W2114816256 @default.
• W475345 cites W2115472834 @default.
• W475345 cites W2125024205 @default.
• W475345 cites W2129539804 @default.
• W475345 cites W2130077869 @default.
• W475345 cites W2131042246 @default.
• W475345 cites W2135686580 @default.
• W475345 cites W2135950058 @default.
• W475345 cites W2153415288 @default.
• W475345 cites W2162452494 @default.
• W475345 cites W2404394550 @default.
• W475345 cites W4413142 @default.
• W475345 cites W7652511 @default.
• W475345 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24129143" @default.
• W475345 hasPublicationYear "2013" @default.
• W475345 type Work @default.
• W475345 sameAs 475345 @default.
• W475345 citedByCount "15" @default.
• W475345 countsByYear W4753452014 @default.
• W475345 countsByYear W4753452016 @default.
• W475345 countsByYear W4753452017 @default.
• W475345 countsByYear W4753452018 @default.
• W475345 countsByYear W4753452019 @default.
• W475345 countsByYear W4753452020 @default.
• W475345 countsByYear W4753452022 @default.
• W475345 countsByYear W4753452023 @default.
• W475345 crossrefType "journal-article" @default.
• W475345 hasAuthorship W475345A5016156476 @default.
• W475345 hasAuthorship W475345A5045284474 @default.
• W475345 hasAuthorship W475345A5064594935 @default.
• W475345 hasAuthorship W475345A5073365136 @default.
• W475345 hasAuthorship W475345A5075216140 @default.
• W475345 hasConcept C126322002 @default.
• W475345 hasConcept C141071460 @default.
• W475345 hasConcept C159654299 @default.
• W475345 hasConcept C203014093 @default.
• W475345 hasConcept C2775915377 @default.
• W475345 hasConcept C2776694085 @default.
• W475345 hasConcept C2776755627 @default.
• W475345 hasConcept C2776912625 @default.
• W475345 hasConcept C2777058396 @default.
• W475345 hasConcept C2777785397 @default.
• W475345 hasConcept C2779134260 @default.
• W475345 hasConcept C2779561371 @default.
• W475345 hasConcept C2779912601 @default.
• W475345 hasConcept C2780091579 @default.
• W475345 hasConcept C2780252810 @default.
• W475345 hasConcept C2780306776 @default.
• W475345 hasConcept C2780678043 @default.
• W475345 hasConcept C71924100 @default.
• W475345 hasConcept C90924648 @default.
• W475345 hasConceptScore W475345C126322002 @default.
• W475345 hasConceptScore W475345C141071460 @default.
• W475345 hasConceptScore W475345C159654299 @default.
• W475345 hasConceptScore W475345C203014093 @default.
• W475345 hasConceptScore W475345C2775915377 @default.
• W475345 hasConceptScore W475345C2776694085 @default.
• W475345 hasConceptScore W475345C2776755627 @default.
• W475345 hasConceptScore W475345C2776912625 @default.
• W475345 hasConceptScore W475345C2777058396 @default.
• W475345 hasConceptScore W475345C2777785397 @default.
• W475345 hasConceptScore W475345C2779134260 @default.
• W475345 hasConceptScore W475345C2779561371 @default.
• W475345 hasConceptScore W475345C2779912601 @default.
• W475345 hasConceptScore W475345C2780091579 @default.
• W475345 hasConceptScore W475345C2780252810 @default.
• W475345 hasConceptScore W475345C2780306776 @default.
• W475345 hasConceptScore W475345C2780678043 @default.
• W475345 hasConceptScore W475345C71924100 @default.
• W475345 hasConceptScore W475345C90924648 @default.
• W475345 hasIssue "4 Suppl 78" @default.
• W475345 hasLocation W4753451 @default.
• W475345 hasOpenAccess W475345 @default.
• W475345 hasPrimaryLocation W4753451 @default.
• W475345 hasRelatedWork W1886500020 @default.
• W475345 hasRelatedWork W2133215767 @default.
• W475345 hasRelatedWork W2162352347 @default.

• next